Generalized Anxiety Disorder Market: Facts, Figures and Analytical Insights 2021-2030

The Generalized Anxiety Disorder Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/12182507952/generalized-anxiety-disorder-pipeline-insight-2020/inquiry?Mode=12      

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Generalized Anxiety Disorder Market: Avinueuro Pharmaceuticals, Fabre-Kramer Pharmaceuticals and others. 

Some surprisingly good news about anxiety

January 7, 2020: Anxiety disorders are the most common type of psychiatric illness, yet researchers know very little about factors associated with recovery. A new University of Toronto study investigated three levels of recovery in a large, representative sample of more than 2,000 Canadians with a history of generalized anxiety disorder (GAD).

The study reports that 72% of Canadians with a history of GAD have been free of the mental health condition for at least one year. Overall, 40% were in a state of excellent mental health, and almost 60% had no other mental illness or addiction issues, such as suicidal thoughts, substance dependence, a major depressive disorder or a bipolar disorder, in the past year,

The definition of excellent mental health sets a very high bar. To be defined in excellent mental health, respondents had to achieve three things: 1) almost daily happiness or life satisfaction in the past month, 2) high levels of social and psychological well-being in the past month, and 3) freedom from generalized anxiety disorder and depressive disorders, suicidal thoughts and substance dependence for at least the preceding full year.

Key Products

AVN101
FKW00GA

Overview:

Generalized anxiety disorder (GAD) is a common and disabling illness that is often underdiagnosed and undertreated. GAD is characterized by at least 6 months of persistent and excessive anxiety. Patients with GAD are at increased risk for suicide as well as cardiovascular-related events and death. Most patients can be diagnosed and managed by primary care physicians. Having low socioeconomic status; being widowed, separated, or divorced; or being middle-aged increases risk for GAD. Additional risk factors include comorbid psychiatric disorders, history of substance abuse or trauma, and family history of GAD.

Symptoms

The symptoms of Generalized Anxiety Disorder include:

Chronic, pervasive anxiety and worry accompanied by nonspecific physical and psychological symptoms (restlessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbances).

Diagnosis

When evaluating patients for GAD, clinicians should consider medical conditions (for example, cardiac, pulmonary, or endocrine illnesses), mood and other anxiety disorders, adverse effects of prescribed or over-the-counter medications and supplements, and substance misuse and withdrawal. Several physical and mental disorders can mimic or co-occur with GAD. Most patients with GAD can be diagnosed by a primary care physician. However, in cases of diagnostic uncertainty or multiple comorbid mental health conditions, clinicians should consider obtaining a second opinion from a psychologist, psychiatrist, or other mental health specialist.

Treatment

Cognitive behavioral therapy (CBT) is to identify and change unhelpful thoughts and behaviors to improve emotions and quality of life. Some CBT techniques, especially exposure therapy, may temporarily increase distress but eventually lead to reduction in chronic anxiety. Types of exposure therapy include imaginal (vividly imagining the feared object, situation, or activity), in vivo (directly facing a feared object, situation, or activity in real life), and interoceptive (deliberately bringing on physical sensations that are harmless but feared). Other commonly used techniques in CBT include education; goal setting; selfmonitoring; cognitive restructuring; relaxation training, including biofeedback; and problem solving. Clinicians should offer drug therapy if nondrug therapies are ineffective or the patient is not interested in them. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) are recommended as first-line drug therapies because of their tolerability and efficacy compared with other drug therapies.

Generalized Anxiety Disorder Emerging Drugs Chapters

This segment of the Generalized Anxiety Disorder report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Buy This Report:

https://www.marketinsightsreports.com/report/purchase/12182507952?mode=su?Mode=12      

Influence Of The Generalized Anxiety Disorder Market Report:

-Comprehensive assessment of all opportunities and risk in the Generalized Anxiety Disorder market.

- Generalized Anxiety Disorder market recent innovations and major events.

-A Detailed study of business strategies for growth of the Generalized Anxiety Disorder market-leading players.

-Conclusive study about the growth plot of Generalized Anxiety Disorder market for forthcoming years.

-In-depth understanding of Generalized Anxiety Disorder market-particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Generalized Anxiety Disorder market.

What Are The Market Factors That Are Explained In The Report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Analytical Tools: The Global Generalized Anxiety Disorder Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

The report has 150 tables and figures browse the report description and TOC:

https://www.marketinsightsreports.com/reports/12182507952/generalized-anxiety-disorder-pipeline-insight-2020?Mode=12

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (sales@marketinsightsreports.com).

Contact Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.